Haemonetics Stock Price Prediction
| HAE Stock | USD 85.55 0.12 0.14% |
Oversold Vs Overbought
79
Oversold | Overbought |
Quarterly Earnings Growth 0.375 | EPS Estimate Next Quarter 1.23 | EPS Estimate Current Year 3.96 | EPS Estimate Next Year 4.4 | Wall Street Target Price 110.8 |
Using Haemonetics hype-based prediction, you can estimate the value of Haemonetics from the perspective of Haemonetics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Haemonetics to buy its stock at a price that has no basis in reality. In that case, they are not buying Haemonetics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Haemonetics after-hype prediction price | USD 85.18 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Haemonetics |
Haemonetics After-Hype Price Prediction Density Analysis
As far as predicting the price of Haemonetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Haemonetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Haemonetics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Haemonetics Estimiated After-Hype Price Volatility
In the context of predicting Haemonetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Haemonetics' historical news coverage. Haemonetics' after-hype downside and upside margins for the prediction period are 82.99 and 87.37, respectively. We have considered Haemonetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Haemonetics is very steady at this time. Analysis and calculation of next after-hype price of Haemonetics is based on 3 months time horizon.
Haemonetics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Haemonetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Haemonetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Haemonetics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 2.19 | 0.37 | 0.33 | 12 Events / Month | 11 Events / Month | In about 12 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
85.55 | 85.18 | 0.43 |
|
Haemonetics Hype Timeline
On the 25th of November Haemonetics is traded for 85.55. The entity has historical hype elasticity of -0.37, and average elasticity to hype of competition of -0.33. Haemonetics is forecasted to decline in value after the next headline, with the price expected to drop to 85.18. The average volatility of media hype impact on the company price is about 112.31%. The price depreciation on the next news is expected to be -0.43%, whereas the daily expected return is currently at 0.19%. The volatility of related hype on Haemonetics is about 124.23%, with the expected price after the next announcement by competition of 85.22. About 99.0% of the company shares are owned by institutional investors. The book value of Haemonetics was currently reported as 17.44. The company has Price/Earnings To Growth (PEG) ratio of 1.55. Haemonetics had not issued any dividends in recent years. The entity had 2:1 split on the 3rd of December 2012. Considering the 90-day investment horizon the next forecasted press release will be in about 12 days. Check out Haemonetics Basic Forecasting Models to cross-verify your projections.Haemonetics Related Hype Analysis
Having access to credible news sources related to Haemonetics' direct competition is more important than ever and may enhance your ability to predict Haemonetics' future price movements. Getting to know how Haemonetics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Haemonetics may potentially react to the hype associated with one of its peers.
Haemonetics Additional Predictive Modules
Most predictive techniques to examine Haemonetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Haemonetics using various technical indicators. When you analyze Haemonetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Haemonetics Predictive Indicators
The successful prediction of Haemonetics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Haemonetics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Haemonetics based on analysis of Haemonetics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Haemonetics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Haemonetics's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.011 | 0.00976 | Price To Sales Ratio | 3.31 | 4.27 |
Story Coverage note for Haemonetics
The number of cover stories for Haemonetics depends on current market conditions and Haemonetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Haemonetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Haemonetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Haemonetics Short Properties
Haemonetics' future price predictability will typically decrease when Haemonetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Haemonetics often depends not only on the future outlook of the potential Haemonetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Haemonetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 51.4 M | |
| Cash And Short Term Investments | 178.8 M |
Complementary Tools for Haemonetics Stock analysis
When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |